Novo Nordisk announced the main clinical trial results of Reimagine 2. Novo Cagrisema demonstrated a weight loss effect of up to 14.2%. Cagrisema shows better weight loss effects compared to SemaglutideWallstreetcn·Feb 2 at 03:45 PM688710+4.96%159859+0.52%
AI healthcare and AI pharmaceutical concepts are experiencing volatile adjustments, with PR falling over 18%, R&G Pharma down nearly 15%, and IMIC, BOJI CRO, GOODWILL, and Berry Genomics all dropping more than 5%Wallstreetcn·Jan 15 at 01:50 AM301230+5.29%301333+1.26%
